Eric Topol

The nasal vaccines, of which there have been many, again, by academic labs like Washington University that sold the license out to India and many others too, Emory, Yale.

So we have the brainpower to come up with much better vaccines.

But unlike what you did in COVAX or Operation Warp Feed, finding the funding when there was none and developing this, is there any chance that all this great science that's been published on from great labs all throughout, actually throughout the world, that we're actually going to act on this?

Oh, but we can drink raw milk, right?

Yeah.

I couldn't agree more.

I mean, just to touch on that mucosal nasal vaccine or oral vaccine, this is so promising, all the data that we have.

And yet, this was dropped by the current administration, the money that was coming through BARDA and other sources that was put together to support both nasal and universal vaccines.

So we just abandon it.

Whereas we need to block infections.

And that's, of course, the biggest.

All these people that are anti-vaccine because it says COVID vaccine because, oh, it doesn't block infections.

Well, yeah, it did really well until we had these variants pop out.

And we could also get back to it doing really well if we were vaccinated.

invest and take the nasal vaccine story forward.

No, I couldn't agree with you more about that.

I mean, we need this human immunome work.

There's a project that started at Yale, but it doesn't have that much funding.

but to understand this complex system, we're going to start to see in the beginning of next year, these so-called immune system clocks that will tell us the pace of a person's immune system aging, which is important in people who are older, just because some of them are immunosenescent already.

And it's good to know that, especially when you're giving them a vaccine and you're hoping they're going to work really well, but lots of other reasons as well.